onset AF

Related by string. * onsets . ONSET . Onset : partial onset seizures . onset atrial fibrillation . Inca Onset S# . onset Alzheimer disease . onset seizures . symptom onset . onset diabetes . infantile onset Pompe . onset diabetes mellitus . late onset hypogonadism / afer . Afer . AFD . AFED . AFER . aF . AFS . afs . af : af fairs . Af fairs . af * ing . af ter . Af rica . af * cking . af * ck . ENGAGE AF TIMI . Priority AF * *

Related by context. Frequent words. (Click for all words.) 58 Phase 1b trial 57 elotuzumab 57 Phase Ib clinical 57 pertuzumab 57 pharmacodynamic effects 57 etravirine 57 double blinded placebo 56 ocrelizumab 56 placebo controlled studies 56 phase IIa 56 Phase IIa trial 56 Phase 2b study 56 phase IIb 56 ATTRACT 55 ADVATE 55 multicenter clinical 55 antiepileptic drug 55 tanespimycin 55 dose titration 55 INTELENCE 55 therapeutic regimens 55 Phase 1b clinical 55 subgroup analyzes 54 celgosivir 54 PROMACTA 54 prospective observational 54 nab paclitaxel 54 elagolix 54 Phase 2a trial 54 liver transplant recipients 54 acute coronary syndromes ACS 54 adalimumab 54 placebo controlled clinical 54 deforolimus 54 secondary efficacy endpoints 54 ponatinib 54 placebo controlled trials 53 heavily pretreated 53 TELCYTA 53 Cloretazine R VNP#M 53 placebo controlled clinical trials 53 cangrelor 53 figitumumab 53 vicriviroc 53 ADHF 53 cardiac toxicity 53 carotid artery stenting 53 registrational trial 53 atherothrombosis 53 registrational 53 abiraterone acetate 53 mycophenolate mofetil 53 tipranavir 53 pafuramidine 53 HSCT 52 metastatic hormone refractory 52 HER2 positive metastatic breast 52 lipid lowering therapy 52 Allovectin 7 R 52 Empatic 52 RRMS patients 52 iclaprim 52 chemoradiotherapy 52 pharmacokinetic studies 52 dose escalation trial 52 PREOS 52 superficial bladder cancer 52 sunitinib 52 COPAXONE R 52 RSD# 52 Phase Ib 52 lipid lowering drugs 52 VICTRELIS 52 neoadjuvant 52 tocilizumab 52 substudy 52 dose cohorts 52 arterial thrombosis 52 antithrombotic 52 Thrombolysis 52 active comparator 52 PRECiSE 51 placebo controlled randomized 51 randomized Phase 51 MIRCERA 51 denufosol 51 Phase 1b 51 relapsed multiple myeloma 51 OncoVEX GM CSF 51 AZOR 51 prospective multicenter 51 Phase Ia 51 multicenter 51 aclidinium 51 muraglitazar 51 decitabine 51 dose regimens 51 virologic failure 51 Phase 2b trial 51 custirsen 51 Phase III randomized

Back to home page